Joachim Albers
7PUBLICATIONS
49CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 08, 2024
HPV and p53 Status as Precision Determinants of Head and Neck Cancer Response to DNA-PKcs Inhibition in Combination with Irradiation.Liana Hayrapetyan, Selina M Roth, Aurélie Quintin
|Jul 03, 2024
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network.Michaela Poliaková Turan, Rahel Riedo, Matúš Medo
|May 25, 2024
Peposertib, a DNA-PK Inhibitor, Enhances the Anti-Tumor Efficacy of Topoisomerase II Inhibitors in Triple-Negative Breast Cancer Models.Steffie Revia, Felix Neumann, Julia Jabs
|Feb 14, 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical Evidence.Shukui Qin, Hongming Pan, Jean Frédéric Blanc
|Jan 11, 2024
DNA-Dependent Protein Kinase Inhibitor Peposertib Potentiates the Cytotoxicity of Topoisomerase II Inhibitors in Synovial Sarcoma Models.Steffie Revia, Magdalena A Budzinska, Olga Bogatyrova
|Sep 29, 2023
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.Adrian Marino-Enriquez, Jan Philipp Novotny, Doga C Gulhan
Pageof 2
Frequent Collaborators
2 joint publications
Manja Friese-Hamim
2 joint publications
Yitzhak Zimmer
2 joint publications
Andreas Johne
2 joint publications
Daniel M Aebersold
2 joint publications
Michaela Medová
2 joint publications
Matúš Medo
2 joint publications
Rahel Riedo
1 joint publications
Anderson Clark
1 joint publications
Julien G Ott
1 joint publications
Christopher Stroh
